Gray A - Search Results

1

What do we know about managing Dupuytren's disease cost-effectively?

Dritsaki M, Rivero-Arias O, Gray A, Ball C, Nanchahal J. Dritsaki M, et al. Among authors: gray a. BMC Musculoskelet Disord. 2018 Jan 25;19(1):34. doi: 10.1186/s12891-018-1949-2. BMC Musculoskelet Disord. 2018. PMID: 29370792 Free PMC article. Review.

2

The multinational nature of cost-effectiveness analyses alongside multinational clinical trials.

Rivero-Arias O, Gray A. Rivero-Arias O, et al. Among authors: gray a. Value Health. 2010 Jan-Feb;13(1):34-41. doi: 10.1111/j.1524-4733.2009.00582.x. Value Health. 2010. PMID: 20667068 Free article. Review.

3

Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial.

Rivero-Arias O, Campbell H, Gray A, Fairbank J, Frost H, Wilson-MacDonald J. Rivero-Arias O, et al. Among authors: gray a. BMJ. 2005 May 28;330(7502):1239. doi: 10.1136/bmj.38441.429618.8F. Epub 2005 May 23. BMJ. 2005. PMID: 15911536 Free PMC article. Clinical Trial.

4

Cost-utility analysis of physiotherapy treatment compared with physiotherapy advice in low back pain.

Rivero-Arias O, Gray A, Frost H, Lamb SE, Stewart-Brown S. Rivero-Arias O, et al. Among authors: gray a. Spine (Phila Pa 1976). 2006 May 20;31(12):1381-7. doi: 10.1097/01.brs.0000218486.13659.d5. Spine (Phila Pa 1976). 2006. PMID: 16721304 Clinical Trial.

5

Current UK Practices on Health Economics Analysis Plans (HEAPs): Are We Using Heaps of Them?

Dritsaki M, Gray A, Petrou S, Dutton S, Lamb SE, Thorn JC. Dritsaki M, et al. Among authors: gray a. Pharmacoeconomics. 2018 Feb;36(2):253-257. doi: 10.1007/s40273-017-0598-x. Pharmacoeconomics. 2018. PMID: 29214388 No abstract available.

6

Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom.

Rivero-Arias O, Gray A, Wolstenholme J. Rivero-Arias O, et al. Among authors: gray a. Cost Eff Resour Alloc. 2010 Apr 27;8:6. doi: 10.1186/1478-7547-8-6. Cost Eff Resour Alloc. 2010. PMID: 20423472 Free PMC article.

7

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A. Petrou S, et al. Among authors: gray a. Appl Health Econ Health Policy. 2015 Oct;13(5):437-43. doi: 10.1007/s40258-015-0191-4. Appl Health Econ Health Policy. 2015. PMID: 26231987 Free PMC article.

8

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A. Petrou S, et al. Among authors: gray a. Pharmacoeconomics. 2015 Oct;33(10):985-91. doi: 10.1007/s40273-015-0319-2. Pharmacoeconomics. 2015. PMID: 26232201 Free PMC article.

9

Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A. Petrou S, et al. Among authors: gray a. J Med Econ. 2015;18(11):851-7. doi: 10.3111/13696998.2015.1070554. Epub 2015 Jul 30. J Med Econ. 2015. PMID: 26295698 Free article.

10

A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).

Kitchener HC, Gittins M, Rivero-Arias O, Tsiachristas A, Cruickshank M, Gray A, Brabin L, Torgerson D, Crosbie EJ, Sargent A, Roberts C. Kitchener HC, et al. Among authors: gray a. Health Technol Assess. 2016 Sep;20(68):1-138. doi: 10.3310/hta20680. Health Technol Assess. 2016. PMID: 27632816 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,043 results

Search Page

Filters